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Abstract Since tools of modern biotechnology have
become available, the most commonly applied and
often discussed genetically modified organisms are
genetically modified crop plants, although genetic
engineering is also being used successfully in organ-
isms other than plants, including bacteria, fungi,
insects, and viruses. Many of these organisms, as with
crop plants, are being engineered for applications in
agriculture, to control plant insect pests or diseases.
This paper reviews the genetically modified non-plant
organisms that have been the subject of permit
approvals for environmental release by the United
States Department of Agriculture/Animal and Plant
Health Inspection Service since the US began regu-
lating genetically modified organisms. This is an
indication of the breadth and progress of research in
the area of non-plant genetically modified organisms.
This review includes three examples of promising
research on non-plant genetically modified organisms
for application in agriculture: (1) insects for insect pest
control using improved vector systems; (2) fungal
pathogens of insects to control insect pests; and (3)
virus for use as transient-expression vectors for
disease control in plants.
Keywords Genetically modified organisms
(GMOs)  GM insects  GM fungi  GM virus
The global adoption of genetically modified (GM) crops,
engineered using the tools of modern biotechnology, has
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steadily increased over the last 30 years. GM crops are
being grown in over twenty-five countries, and this
includes eleven different crops (James 2012). Many
other GM plants are the subject of ongoing research. The
first environmental releases for GM crop plants were
approved in the United States (US), for confined field
trials in 1985 and for unconfined planting (deregulation)
in 1992. GM plants have received significant attention in
the media and have dominated the discussions regarding
risk assessment and regulation among the scientific and
regulatory communities (McHughen and Smyth 2008).
However, the first permits for field trials with genetically
modified organisms (GMOs) in 1985 (or earlier) were
not for plants, but for genetically modified bacteria:
Pseudomonas syringae—the ‘ice-minus’ bacteria (Lin-
dow and Panoupoulus 1988; McHughen and Smyth
2008). There has been steady research on these and
various other non-plant GMOs in the years since.
A good indication of historical and ongoing
research and regulation with non-plant GMOs can be
found in the record of permits issued for environmen-
tal release in the US (See Table 1). The US coordi-
nated framework for the regulation of biotechnology
was established in 1986 (OSTP 1986; McHughen and
Smyth 2008). According to this framework, the US
Department of Agriculture/Animal and Plant Health
Inspection Service (USDA/APHIS) has responsibility
for the regulation of all GM organisms that are a ‘plant
pest’ or have been engineered using ‘plant pests’. To
date, most GMOs have fit within this ‘plant pest’
criteria for regulation by APHIS, although with recent
advances of the technology including targeted gene
modifications and cisgenics that do not use any ‘plant
pests’, some GMOs are not regulated by APHIS
(Kuzma and Kokotovich 2011). However, most
GMOs in the US have required a permit from APHIS
before any ‘controlled’ release into the environment.
These permits are usually for the purposes of research
in field trials, until the GM organism has been
approved following a process of petition to APHIS
for deregulation, after which a permit is no longer
required (USDA 1997).
A comprehensive database (maintained by Infor-
mation Systems for Biotechnology at Virginia Tech)
including all of the permits, as well as deregulations,
can be accessed through the APHIS website (http://
www.aphis.usda.gov/biotechnology/status.shtml).
This database is described as ‘GE crop data’ although
it does include other organisms in addition to crops
(e.g., bacteria, fungi, insects, nematodes, virus). Per-
mits in this database come in two forms: ‘release
permits’ and ‘notifications’. ‘Release permits’ were
required for all organisms originally and now only for
certain GMOs not eligible for the more common
‘notification’. ‘Notifications’ are an abbreviated ver-
sion of a permit initiated by APHIS starting in 1993 for
GMOs that meet certain criterion to be eligible for this
simplified process (USDA 1997). The earliest permits
in the database were issued in 1985. At the time of this
review (June 18, 2013), the database included 18,789
permit requests, of which 16,438 were notifications
and 2,351 were release permits. Although some
(*1,500) of these permit requests were withdrawn or
denied, most have been issued (‘acknowledged’, in the
case of notifications). The earliest release permits, in
1985 and 1986, were ‘accepted’ rather than ‘issued’.
Almost all of these permits have been for plants;
only 155 permit requests are for GMOs that are not
plants. Of these, 20 were withdrawn and two were
denied. Since 1985, 133 ‘release permits’ have been
issued for non-plant GMOs. Of the total permits/
notifications that have been approved, less than one
percent are for non-plant organisms, while approxi-
mately ten percent of permits that were issued in the
first 5 years (1985–1989) were for organisms other
than plants. It should be noted that all non-plant
organism permits issued have been ‘release permits’;
none have been by the simplified ‘notification’. It is
not entirely clear, but it appears from the APHIS
regulations that one eligibility requirement for a
permit under the ‘notification’ option is that the
organism (regulated article) is a plant species (USDA
1997).
A summary from the database of the non-plant
organisms that have been issued environmental
release permits by APHIS is provided in Table 1.
There are 230 different total organisms (plant and non-
plant) listed to search in the database; 38 of these are
non-plant organisms. These numbers somewhat exag-
gerate the actual number of organisms because a few
organisms are listed by different descriptors e.g.,
Xanthomonas campestris pv. vesicatoria is also listed
as Bacterial Spot of Tomato, Cryptonectria parasitica
is also listed as Chestnut Blight, tobacco mosaic virus
is also listed as TMV. In some cases, the database
shows more than one species together with a forward
slash between them, which is as it appears in the
permit application. The descriptors are entered in the
Transgenic Res
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Table 1 Non-plant GM organisms issued permits for environmental release by USDA/APHIS
Total # 
Permits 
Issued  
Years Issued APHIS 
Permit No. 
linked to EA 
in ISB 
database 
1985-1994 1995-2004 2005-present 
BACTERIA 
1tB
Bacterium 1 
Clavibactera 7  2                  7a
Rhizobiumb 6               3b
Erwiniac 3         2c
Xanthomonasd 15  2      2d
Pseudomonase 26 2 2 2 3 2 6e
FUNGI 
Cephalosporium stripe 2  
Aspergillus flavus 5  2 2                
Fusariumf 14  2  2 2          3f
Cryphonectria parasiticag 5  2              94-010-01r 
Neotyphodiumh  2        05-152-01r 
VIRUS 
TEV (Tobacco etch virus) 1  98-120-01r 
Citrus viroid iii 2  99-032-03r 
Citrus tristeza virus 5  2
Tobacco mosaic virus (TMV)i  21  2 2  2  4i
INSECTS 
Western orchard predatory mite 1  
Pink bollworm 15  2 4 2  2j
NEMATODES 
Heterorhabditis bacteriophora 1  
A note is included if there is more than one description in the database list of organisms, or if there is more than one permit linked to an Environmental
Assessment
a Clavibacter, Clavibacter xyli 87-355-01r, 88-355-01r, 89-053-01r, 90-016-01r, 90-333-01r, 91-343-01r, 92-329-01r
b Rhizobium, Rhizobium etli/Rhizobium leguminosarum, Rhizobium etli/Rhizobium leguminosarum/Rhizobium meliloti, Rhizobium fredii/Rhizobium
leguminosarum 90-164-03r, 94-207-02r, 97-071-01r
c Erwinia amylovora, Erwinia carotovora, Pectobacterium carotovorum 03-279-01r, 05-097-01r
d Xanthomonas, Xanthomonas campestris, Xanthomonas campestris pv. vesicatoria, Bacterial Spot of Tomato 89-290-01r, 96-071-06r
e Pseudomonas, Pseudomonas Syringae, Pseudomonas Syringae pv. syringae, Pseudomonas putida 90-135-01r, 91-023-06r, 93-026-04r, 95-130-01r,
97-023-02r, 97-023-01r
f Fusarium graminearum, Fusarium graminearum/Fusarium sporotrichioides, Fusarium moniliforme, Fusarium verticillloides 94-006-01r, 95-003-
01r, 98-355-01r
g Cryphonectria parasitica, Chestnut Blight
h Neotyphodium sp., Neotyphodium sp. Lpl Endophyte
i Tobacco Mosaic Virus (TMV), TMV 91-007-08r, 94-081-01r, 95-041-01r, 96-051-04r
j 01-029-01r, 05-098-01r
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database according to how they are described in the
permit application that was submitted to APHIS.
Where more than one descriptor in the database has
been combined into one row in Table 1, the different
descriptors are given in a footnote. Some organisms
are grouped by genus for the table. Note that in the
database the list of all organisms will show some non-
plant organisms there that are not included in Table 1,
such as Agrobacterium tumefaciens and Eschericia
coli. These organisms are not included in the table
because the permit requests were withdrawn before
they were issued. Table 1 only includes organisms for
which permits have been issued.
The total number of permits that have been issued
for each organism, and the years in which the permits
were issued are also shown in Table 1. Some organ-
isms were issued permits early on, but there have been
no additional requests for a permit in the last 10 years,
including all permits for Rhizobium species which
only occurred before 2001, and only one permit for a
nematode in 1996. Organisms with the most permits
issued include 22 for Pseudomonas syringae (span-
ning the entire period from 1985 to 2013), 21 for
Tobacco Mosaic Virus (from 1991 to 2013), and 15 for
pink bollworm (from 2001 to 2013). There have been
permits for several different bacteria and fungi over
the years, but only two insects have been the subject of
a release permit, as well as four viruses/viroids.
Table 1 also provides the permit number for any
permit for these organisms that is linked to an
environmental assessment (EA) in the database.
APHIS does not prepare an EA for every release
permit issued, usually only those that raise new risk
issues. There is at least one EA on record for every
organism or similar organisms, with a few exceptions.
For some organisms, multiple EAs have been
prepared. The full record in the database (opened by
selecting the permit number) includes the name of the
submitting institution and a brief (although very
vague) description of the phenotype and genes, as
well as location, and acres if available. More infor-
mation about these particular cases of nonplant
GMOs, including the purpose of the transformation,
can be found by accessing the EA, if there is one, from
the full record in the database, or in the literature. It
should also be noted that these EA are all for
‘controlled’ environmental releases and consider the
adequacy of the confinement measures to minimize
the risks that could be associated with an unconfined
release. APHIS has not ‘deregulated’ a non-plant
organism to date. It is likely that some of these non-
plant organisms are intended to only be used under a
permit.
The following review provides three examples of
research by the authors, on non-plant GMOs being
developed for agricultural purposes: (1) insects for
insect pest control using improved vector systems;
(2) fungal pathogens of insects to control insect
pests; and (3) virus for use as transient-expression
vectors for disease control in plants. Each of these
examples is a summary of a presentation that was
given by the authors in a plenary session on the topic
of non-crop applications of GMOs at the 2012
ISBGMO12 conference in St. Louis, MO USA.
These examples demonstrate the potential of using
genetically engineered ‘‘non-plant’’ organisms and
suggest that the regulatory community should be
prepared to consider the risks and benefits of these
organisms.
Development of transgenic strains for biologically-
based control and ecological safety in tephritid pest
insects
The development of transgenic insect strains has
advanced rapidly, with nearly 30 species within five
orders of insects being genetically transformed
(O’Brochta and Handler 2008). Gene transfer provides
the opportunity to create transgenic strains that may be
used directly to control the population size or behavior
of agriculturally and medically important insects.
Transgenic strains may be created to improve existing
biologically-based control strategies, such as the
sterile insect technique (SIT; Knipling 1955), or to
provide the means for new strategies for biologically-
based control based on conditional lethality systems
(see Alphey 2002; Handler 2002). For beneficial
insects, their fitness, reproductive capacity, and
behavior, or their ability to produce and process
proteins, may be improved. For vectors of disease, an
alternative to suppressing population size is their
transformation into inhospitable hosts for the parasites
or pathogens they normally transmit (James 2005).
The potential applications of genetically trans-
formed insects must, however, be viewed in light of
limitations that are inherent to the gene-transfer vector
systems used to integrate transgenes into the host
Transgenic Res
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genome (O’Brochta and Handler 2008). All of the
heritable germ-line transformations in insects have
been achieved with vectors derived from transposable
elements, which currently include Hermes, mariner,
Minos, and piggyBac. While these elements provide
advantages over other types of vectors and transfor-
mation strategies, a major consideration is their
potential for re-mobilization by an unintended source
of transposase, and the random nature of transposon
integration into host genomes, both of which can
adversely affect program effectiveness and ecological
safety (Handler 2004; FAO/IAEA Report 2002).
First, while the transposase enzyme required for
transposon excision/insertion is typically eliminated
after integration, the unintended or undetected pre-
sence of genes for the transposase, or related enzymes,
within the host can result in vector re-mobilization
(Sundararajan et al. 1999). While generally not
considered to be problematic for small-scale labora-
tory studies, the rearing and release of many millions
(if not billions) of insects for bio-control programs
increases the probability that such rare events may
occur. Secondly, the random nature of genomic
transposon integrations, including sites within coding
and enhancer/promoter regulatory regions, result in
insertional mutations (Horn et al. 2003; Wilson et al.
1989) that often have deleterious effects on the
transformed host’s fitness and viability (Catteruccia
et al. 2003; Irvin et al. 2004). Localized genomic
position effects on gene expression also result in
variable transgene expression depending upon the
integration site (Schotta et al. 2003). Thus random
integrations make true comparative gene expression
studies impossible, and host fitness and viability is
often negatively affected, as is the efficiency of
creating optimal strains for applied use. Importantly,
variable expression of lethal effector genes could
result in the unintended survival of transgenic insects
in the field, or suppression of marker genes used for
identification of transgenic individuals.
To address these limitations on transgenic insects,
we developed new transgene vectors that can be
immobilized post integration for enhanced stability,
and which can provide acceptor sites for subsequent
targeted transgene integrations. After their initial
integration, optimal genomic target sites would
include those that do not negatively affect transgene
expression by position effects, or result in insertional
mutations. These vectors were first tested individually
and then in combination in an integrated targeting/
stabilization system in Drosophila melanogaster
(Handler et al. 2004; Horn and Handler 2005). We
have since modified these vectors for more efficient
and flexible use in tephritid fruit fly species to test their
function (Schetelig et al. 2009), and have initiated the
creation of a series of stabilized target-site strains that
can be used to create transgenic strains for biological
control and functional genomics analysis (Meza et al.
2011). This new generation of transformation vectors
is expected to increase the efficiency of transgenic
strain development and strain effectiveness, while
improving their ecological safety. It is likely that use
of these strategies, if not the genetic components
themselves, may be extended to other transgenic
organisms as well.
Vector stabilization by post-integration terminal
sequence deletion in Drosophila
To stabilize transposon vectors subsequent to genomic
integration we took an approach that was initially
tested in Drosophila (Handler et al. 2004), and is
simply applicable to all species subject to transposon-
mediated transformation. This was achieved by intro-
ducing an internal tandem duplication of one of the
transposon inverted terminal sequences (ITR), either
from the 50 or 30 terminus, which are both required for
transposon mobility. If the 50 ITR and 30 ITR are
designated as L1 and R1 (for left- and right-arm),
respectively, and the internal ITR sequence is L2, then
the stabilization vector configuration would be L1-L2-
R1. Within this vector, distinguishable marker genes
(M1 and M2) are placed between ITR sequences, and
genes of interest (GOI) to be stabilized are placed in
between the duplicated ITRs. Thus the final construct
may be represented as L1-GOI-M1-L2-M2-R1. Once
this stabilization vector has been transformed into a
host genome, it may re-mobilized in two ways after
providing exogenous transposase. Mobilization of the
L1 and R1 ITRs together would result in complete loss
of the vector, as determined by loss of both markers.
However, mobilization of R1 with the internal L2 ITR
would result in the loss of only the L2-M2-R1
sequence, with the L1-GOI-M1 construct remaining
as a genomic transgene insertion. In this instance, the
absence of a 30 R1 terminal sequence would prohibit
any future mobilization of L1-GOI-M1 by an unin-
tended source of transposase.
Transgenic Res
123
This system was first tested for stability in
Drosophila using the piggyBac transformation vector,
by mating a stabilized L1-PUbDsRed1 line to a
jumpstarter strain (having a chromosomal source of
transposase) which showed that no remobilization of
the remaining transgene occurred (by loss of pheno-
type) in more than 7,000 progeny assayed. This was
compared to a *5 % remobilization rate in the
original L1-PUbDsRed1-L2-3xP3-ECFP-R1 vector,
indicating that the L1-PUbDsRed1 transgene was
stabilized owing to the loss of the 30 piggyBac
terminus.
Modified stabilization vectors were subsequently
created for tephritid species and tested in the medfly,
Ceratitis capitata (Schetelig et al. 2009), mexfly,
Anastrepha ludens (Meza et al. 2011), and caribfly,
Anastreph suspensa (A. M. Handler, unpublished
data). These vectors were stabilized by either mating
to a jumpstarter strain in medfly, or injecting a
transposase helper plasmid in the Anastrepha species.
Stability in the presence of transposase was confirmed
quantitatively in C. capitata by testing more than
70,000 progeny (Schetelig et al. 2009).
RMCE targeting and stabilization vectors
An efficient gene targeting method for insects was
based on a recombinase-mediated cassette exchange
(RMCE) strategy first developed for genomic target-
ing in mammalian stem cells (Baer and Bode 2001).
We first tested RMCE in Drosophila (Horn and
Handler 2005) using the FRT/FLP recombination
system (Andrews et al. 1985; Siegal and Hartl 1996)
by designing a transposon acceptor vector that once
integrated by piggyBac transformation (Handler et al.
1998), could act as a target-site for subsequent donor
vector insertions by double-recombination of variant
FRT sites (see Horn and Handler 2005, Fig. 2). In this
system, the RMCE transformation vector has an
acceptor target site that consists of hetero-specific
FRT and FRT3 recombination sites (RSs), that can
only recombine with their identical RS, but not with
each other (i.e. FRT 9 FRT and FRT3 9 FRT3, but not
FRT 9 FRT3). These were placed in a tandem
orientation, flanking a marker gene to create an
exchange cassette. Once integrated by transposon-
mediated transformation, the FRT/FRT3 cassette was
targeted for exchange by a donor vector having the
same hetero-specific RSs, but with a different internal
marker. After injection into target strain embryos with
plasmid-encoded FLP recombinase, RMCE was
observed in the progeny of the injected embryos by
loss of the acceptor vector marker, and appearance of
the donor vector marker, which was verified by target-
site sequencing and DNA hybridization. The valida-
tion of FRT/FRT3 RMCE in an insect species suggests
that, depending on the number of hetero-specific RSs
and their position in a target site, a variety of cassette
exchange, insertion and deletion events may be
achieved, and continued repetitively by the insertion
of new RS sequences.
Stabilization of the target-site vector by RMCE was
then tested by incorporating a piggyBac 30-ITR
(pBacR2) sequence linked to a PUb-DsRed marker
within an FRT/FRT3 donor cassette. After RMCE, the
donor pBacR2 sequence was remobilized with the
acceptor vector’s piggyBac 50-ITR (pBacL1), resulting
in genomic stabilization of the original acceptor vector
piggyBac 30 (pBacR1) sequence and associated genes of
interest. In this way, stabilization of a desired genomic
target site could be achieved in a two-step process.
A loxP-based RMCE system was also tested in
Drosophila by Oberstein et al. (2005) using the
P transformation system to genomically integrate an
acceptor target-site vector, that recombined with a
donor cassette in the presence of Cre recombinase using
eye color mutant-rescue to mark recombinants. Donor/
target cassette exchange occurred reliably, though the
system was specific for use in Drosophila (Oberstein
et al. 2005) in terms of the P vector system used, and the
visible mutation markers used to follow the process.
Recently we tested a new Cre/lox RMCE system that
showed function for the first time in a nondrosophilid
species, A. suspensa, as well as in Drosophila (Schete-
lig and Handler 2013). The unidirectional phiC31
integrase recombination system (Groth et al. 2004) has
also been tested for site-specific attB/attP genomic
targeting in C. capitata (Schetelig et al. 2009), as well
as in several mosquito species.
The premise of this work is that vectors that allow
RMCE-based genomic targeting with a post-integra-
tion stabilization component will greatly enhance the
effectiveness and safety of transgenic strains used in
field release for biocontrol. They will also greatly
reduce the time and effort needed to create these
strains by avoiding genomic integration sites that
negatively effect strain fitness and transgene expres-
sion, and will allow direct ‘‘allelic’’ comparisons of
Transgenic Res
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different recombinant DNA strategies by comparative
gene expression studies that identify and optimize
ideal promoter and effector sequences. The ability to
stabilize transgenes will minimize ecological risks by
ensuring predictable transgene marker expression that
could be compromised by intra-genomic movement,
and by limiting the potential for inter-genomic move-
ment that could result in transfer of transgenes to
unintended host species. The RMCE strategy will be
equally important to functional genomics analysis,
both for model systems and insects important to
agriculture and human health. Transposon-based vec-
tors are inherently limited by the size insert they can
carry, but recombinase systems are not (and indeed,
they facilitate chromosomal rearrangements). Thus,
repetitive anchoring (or replacement) of different
transgene cassettes at identical loci will be possible,
without restriction on gene size or number, allowing
continued modification of established strains for
improved efficacy and ecological safety (e.g.
improved marker and lethality systems) of genetically
modified insects.
Strain improvement of the insect pathogen
Metarhizium
Fungi are the most common pathogens of insects in
nature, and perhaps the most well suited microbes for
development as biopesticides because unlike bacteria
and viruses they infect insects by direct penetration of
the cuticle and so function as contact insecticides.
While many of the approximately 1,000 known
species of entomopathogenic fungi have narrow host
ranges, collectively they target most if not all insect
species including sucking insects, and the many
coleopteran and orthopteran pests, among others,
which have few known viral or bacterial diseases.
Industrial production of Metarhizium spp. is highly
automated and the price of commercialized Metarhiz-
ium acridum for locust control in Africa, Australia,
and China works out at US$20/ha for 50 g/ha, which is
similar to the price of conventional chemical insecti-
cides (Langewald and Kooyman 2007). However,
fungal pathogens have a small market share because of
inconsistencies in performance and low virulence
(slow kill and high inoculum load) compared to the
chemicals with which they compete. Low efficacy
could be inbuilt because an evolutionary balance may
have developed between microorganisms and their
hosts so that quick kill, even at high doses, is not
adaptive for the pathogen, in which case cost-effective
biocontrol will require genetic modification of the
fungus (Gressel 2007). Better understanding of fungal
pathogenesis in insects and the availability of efficient
tools for genetic manipulation is alleviating efficacy
limitations by allowing construction of transgenic
strains with improved ability to kill insects, tolerate
adverse conditions and tackle vector-borne diseases.
With increasing public concern over the continued use
of synthetic chemical insecticides, these new types of
biological insecticides offer a range of environmental
friendly options for cost-effective control of insect
pests (Federici et al. 2008).
Genetic engineering to improve virulence has
focused on reducing both lethal spore dosage and
time to kill. Reducing spore dosage improves infection
rates allowing control to be achieved with less
product. It also increases effective persistence of the
biopesticide because as spores decay there is a greater
probability that an insect will come into contact with
enough propagules of the genetically modified fungus
to exceed the inoculums threshold (Thomas and Read
2007). Most studies to date have exploited the insect
pathogenic fungi themselves as a resource of genes for
strain improvement. In the first example of a
recombinant fungal pathogen with enhanced viru-
lence, additional copies of the gene encoding the
regulated cuticle degrading protease Pr1 were inserted
into the genome of Metarhizium anisopliae and
constitutively overexpressed. The resultant strain
showed a 25 % mean reduction in survival time
(LT50) toward Manduca sexta as compared to the
parent wild-type strain (St. Leger et al. 1996).
Importantly, a Pr1 overexpressing strain of M. ani-
sopliae was used in the first EPA approved field trial of
a transgenic fungal pathogen, thus setting a precedent
and paving the way for future trials (Hu and St. Leger
2002). The complete sequencing of M. acridum and
Metarhizium robertsii has been completed and is
helping determine the identity, origin, and evolution of
traits needed for diverse lifestyles and host switching
(Gao et al. 2011). Success in developing transgenic
organisms will benefit from knowledge of the signal
transduction pathways that regulate pathogenesis,
particularly host range, and the availability of a wide
range of suitable genes that can be used to increase
virulence. An esterase involved in mobilizing internal
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nutrients in the broad host range M. robertsii was used
to transform the locust-specific M. acridum into a
caterpillar pathogen (Wang et al. 2011).
In spite of their potential for strain improvement,
microbial genes have not yet produced the leap to
hypervirulence necessary for a breakthrough product.
Arthropod neuropeptides are a particularly attractive
alternative to microbial toxins as they offer a high
degree of biological activity, and rapidly degrade in
the environment providing environmental safety
(Edwards and Gatehouse 2007). Over one million
peptide toxins have been isolated from arachnids and
scorpions, but their use for pest control has been
limited since they are not toxic by oral administration,
and require a means of delivery into the circulatory
system. We combined some of these toxins with the
natural ability of insect pathogenic fungi to penetrate
into insects. We initially tested AaIT (an insect
specific sodium channel blocker) because it is well
studied and very potent and so would provide a
benchmark for efficacy (Zlotkin et al. 2000). The
modified M. anisopliae expressing AaIT under the
control of a hemolymph-specific promoter (to prevent
expression outside an insect) achieved the same
mortality rates in tobacco hornworm (M. sexta) at
22-fold lower spore doses than the wild type (Wang
and St. Leger 2007). Similar results were obtained
with mosquitoes (LC50 reduced ninefold) and Broca
(coffee berry borer beetle; LC50 reduced 16-fold)
(Pava-Ripoll et al. 2008). Toxins from funnel web
spiders have proven to be even more potent than AaIT
against some insects (Fang, St. Leger, unpublished
data).
There are many international crop pest and disease
problems that are amenable to biotechnology solutions.
Many of these problems could require transgenic
technology for which there is only a beginning
precedent being set. There is willingness in the
regulatory community to take on these issues, but what
is most needed are clear and compelling needs, such as
malaria control. As described above, the virulence of M.
anisopliae can be increased to a remarkable extent by
expressing a scorpion toxin (AaIT) (Pava-Ripoll et al.
2008). However, mosquitoes are notoriously adept at
out-evolving control strategies, and a slow speed of kill
that enables mosquitoes to achieve part of their lifetime
reproductive output could reduce selection pressure for
mosquitoes to develop resistance to the biopesticide
(Thomas and Read 2007, Read et al. 2009). Fungal
strains that greatly reduce mosquito infectiousness
could improve disease control without increasing the
spread of resistance (Thomas and Read 2007). To
achieve this effect, we produced recombinant strains
expressing molecules that target sporozoites as they
travel through the hemolymph to the salivary glands.
Our best strain reduced the sporozoite intensity approx-
imate 98 %. Additional benefits included decreased
host feeding (and therefore transmission potential) and
increased mosquito mortality (Fang et al. 2011).
Metarhizium anisopliae’s ability to express a func-
tional single-chain antibody fragment is notable (Read
et al. 2009) because recombinant antibodies provide a
vast array of potential antiparasite and anti-arthropod
effectors that could target, for example, insect hormone
receptors. These would facilitate construction of very
effective, highly specific, biopesticides with minimal
increased potential for negative environmental impact
relative to their parental wild-type strains. The rich
arsenal of antiparasite and anti-insect proteins makes it
possible that new transgenic strains can be developed
that stay one step ahead of the insect or parasite evolving
resistance. Given their ease of genetic manipulation,
Metarhizium and Beauveria provide a tractable model
system for screening novel effectors or fusion products
produced by gene shuffling. The most potent anti-insect
or antimicrobial effectors could then be delivered by the
fungus, another microbe, and/or in a transgenic insect or
plant. Likewise, insect pathogenic fungi could be used to
test various metabolic pathways for their ability to
enhance tolerance to abiotic stresses. Given the increas-
ing public acceptance of GMOs, particularly crops
expressing B. thuringiensis toxins (Federici et al. 2008),
field application of GM insecticidal microbes should
have a bright future if care is taken to ensure social
acceptance through rigorous risk benefit analysis.
Changing an enemy into an ally to manage citrus
diseases
The ability to express foreign genes or to silence
endogenous genes in plants has revolutionized both
basic and applied plant biology. Foreign genes can be
expressed in plants either by permanent insertion into
the genome or by transient expression using virus-
based vectors. Each approach has distinct advantages.
While the insertion of genes into the plant genome is
generally permanent, expression by viral vectors
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occurs only for a limited period of time. In genetically
improving plants, these systems are complementary.
The potential value and applications of each of these
approaches varies broadly, especially comparing
annual to woody plants (Dawson and Folimonova
2013).
Citrus tristeza virus (CTV) is an endemic virus in
most citrus industries (Bar-Joseph et al. 1989; Bar-
Joseph and Dawson 2008). Although some isolates of
the virus cause serious economic losses, many isolates
cause little damage (Dawson et al. 2013). For exam-
ple, most trees in Florida are infected with isolates of
CTV that cause little damage as long as trees are not
grown on the sour orange rootstock. By recombinant
DNA technologies, we built a transient-expression
vector based on CTV (Folimonov et al. 2007) that
provides systemic expression of foreign genes in
citrus. This vector contains an additional subgenomic
RNA promoter from a related closterovirus to control
expression of a foreign gene of choice in citrus trees.
Using a green fluorescent protein (GFP) as a reporter,
we examined several engineered vector prototypes for
their ability to infect, move, and express GFP
throughout citrus trees. The CTV vector is limited to
phloem-associated cells. The vector provides expres-
sion of a foreign protein at very high levels and has
been unusually stable, having continually produced
foreign proteins in trees for more than 10 years so far.
This vector can be graft transmitted and expressed in a
range of citrus varieties of different ages.
The original objective was to build a vector as a tool
for citrus improvement. With the emergence of the
citrus greening (huanglongbing: HLB) disease into
Florida, we began screening genes for activity against
the bacterial pathogen or the psyllid vector, with the
intention of building transgenic citrus with the genes
found to be effective. However, the spread of greening
in Florida has been more rapid than expected and the
disease is debilitating trees. The majority of citrus
produced in Florida is for juice. Since juice processing
plants require a minimum amount of fruit for process-
ing to remain open and the fear is that production will
start declining, it is possible that processing plants will
have to close unless developments are made to stabilize
fruit production. Although it is likely that transgenic
citrus trees will be a long-term answer to the citrus
greening problem, there is concern that they will not be
available in adequate numbers in time to save the
industry. There is desperate need to find solutions more
quickly than transgenic trees. For those reasons, the
CTV vector is being considered as a temporary measure
to protect trees until transgenic trees become available.
The advantage of the CTV vector with an anti-HLB
gene over transgenic plants is that the vector can be
deployed sooner. A major reason is that since the virus
does not affect the production and quality of trees, there
is no need for evaluation as is needed with transgenic
trees and the virus can utilize trees that are beyond
juvenility. Another advantage of the CTV vector is that
if effective genes or RNAi molecules can be found, the
vector could be used to treat trees in the field that are
already infected with HLB (Dawson and Folimonova
2013). From an environmental standpoint, the CTV
vector adds nothing permanently to the environment.
With time, the vector deletes all of the inserted
sequences and becomes identical to the endemic virus
already prevalent in most citrus trees.
The approach is to find genes that can control the
bacterial pathogen or the psyllid vector to be expressed
by the vector. Since psyllids suck large amounts of
fluid from citrus phloem, the CTV vector can be used
to produce compounds in the citrus phloem to reduce
the number of psyllids. Two different methods are
being considered: antimicrobials to prevent endo-
phytic bacteria in psyllids and the use of RNAi
molecules to target specific enzymes of psyllids.
Trees can be productive for many years—over
100 years in some cases. The question arises: Why just
use a virus-based vector against pathogens and pests?
New technologies are always being produced and
value-added products are being developed. With
transformation, to respond to these developments,
the existing trees have to be removed and the new
transgenic trees be planted. A transient-expression
vector could be used to improve the existing trees in
the field. Another question is ‘Why just citrus?’
Similar vectors could be developed for a range of tree
crops. Virus-based vectors have been used for several
years to produce specialty products in herbaceous
plants. Similar vectors could have completely differ-
ent uses in perennial crops.
Conclusion
The USDA/APHIS database is an easily searchable/
sortable database that includes authorizations of both
crop and non-crop GMOs for agricultural applications.
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It seems probable that the research and progress with
non-crop GMOs in the US is representative of this type
of research worldwide, if not more advanced. Regu-
latory agencies in some other countries maintain
databases of permits and approvals similar to the
USDA/APHIS, although these may not be easy to
search, may only be available in the language of the
country, and may only be for GM crops. There is not a
global database available that captures this informa-
tion. There are several very useful global databases
available for GM crop approvals (e.g., cera-gmc.org
and www.isaaa.org) but these do not include nonplant
organisms.
The biosafety clearing house (BCH), maintained by
the secretariat of the Convention on Biological
Diversity as part of the Cartagena Protocol on
Biosafety (bch.cbd.int), should include information
about approvals for intentional releases into the
environment of any GM organism in countries that
are party to the protocol. However, the BCH database
is currently likely not representative of global approv-
als because several countries that are leaders in GM
approvals are not parties to the protocol (including the
US, Canada, Argentina, Australia), and many coun-
tries that are parties are not up to date in their entries to
the BCH. The BCH is difficult to search, and the level
of detail seems to vary by entry. A search of all
recipient organisms in the BCH revealed very few
nonplant organisms; Only three organisms (Pseudo-
monas fluorescens, pink bollworm, and olive fly) from
this search appeared to be for agricultural applications.
Our review does not include organisms that are
being engineered for applications outside of agricul-
ture specifically. We do not include GM organisms
being engineered for human or animal vaccines
(which are typically regulated as a drug), or GM
mosquitos being engineered for controlling the spread
of human diseases such as malaria or dengue. We also
do not include GM mammals or fish. It should be noted
that there is also significant progress in these areas
of research in the US and in other countries, and
such GMOs are also the subject of biotechnology
regulation.
The noncrop GM organisms listed in Table 1 and
the three detailed examples provided in this review
demonstrate the significant potential for applications
in agriculture of genetic engineering in organisms
other than plants. Some of this research could lead to
methods of control for agricultural diseases and pests
that are more economical or more environmentally
benign than current options of control, or may provide
control where no other solutions are available. This
review highlights research that involves a release into
the environment (i.e., field test), which could be
considered as an indication of advanced progress of a
project toward a product. However, this review must
only represent a portion of the total effort toward this
type of research, because more of this kind of research
is being conducted under contained use conditions in
laboratories or artificial environments where a permit
(in the US) is not required.
As the technology continues to advance and new
tools of biotechnology become available, this kind of
work can be expected to increase in the future. Before
this research will be translated into meaningful
applications, there will be regulatory hurdles, risk
assessment issues, and public acceptance issues, as
there are for GM crops. Product developers and
regulators should consider how these issues may be
similar or different from those encountered with GM
crops, to prepare for successful applications of these
non-plant GMOs.
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